dsco Discovery Laboratories Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : dsco Discovery Laboratories

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (127)	9/14/2007 5:00:54 PM
From: detlef gerlach	Read Replies (1) of 318

I am sure that the batches produced in April have been tested on premature rabbits in the DSCO labs. Just as they had to report failure of this quick and dirty test on preterm rabbits last April, they would have to report this at the end of August if it had occurred. The test measures dynamic pulmonary compliance in these rabbits before and after instillation of Surfaxin. No report of failure of these batches was released, which makes me assume that "so far, so good". Obviously the more detailed tests are being carried out and will take several weeks before the results are submitted to the FDA. The magic date for submission is October. I have quite a few shares and hope the results are good. Who knows though--Capetola has screwed up too many times in the past. Hopefully some of the new folks are keeping a closer eye on the process.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next